Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25481791

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Jan
First author
Oza AM

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Feb;16(2):e55
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2015 Jan;16(1):e6
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  3. citation
    Lancet Oncol. 2015 Jan;16(1):10-2. doi: 10.1016/S1470-2045(14)71172-6.
    note
    Source null
    related pmid
    25481790
    relationship
    Comment in

Authors and identifiers

  1. name
    Oza AM
    type
    Author
  2. name
    Cibula D
    type
    Author
  3. name
    Benzaquen AO
    type
    Author
  4. name
    Poole C
    type
    Author
  5. name
    Mathijssen RH
    type
    Author
  6. name
    Sonke GS
    type
    Author
  7. name
    Colombo N
    type
    Author
  8. name
    Špaček J
    type
    Author
  9. name
    Vuylsteke P
    type
    Author
  10. name
    Hirte H
    type
    Author
  11. name
    Mahner S
    type
    Author
  12. name
    Plante M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Oza AM
    type
    Author
  2. name
    Cibula D
    type
    Author
  3. name
    Benzaquen AO
    type
    Author
  4. name
    Poole C
    type
    Author
  5. name
    Mathijssen RH
    type
    Author
  6. name
    Sonke GS
    type
    Author
  7. name
    Colombo N
    type
    Author
  8. name
    Špaček J
    type
    Author
  9. name
    Vuylsteke P
    type
    Author
  10. name
    Hirte H
    type
    Author
  11. name
    Mahner S
    type
    Author
  12. name
    Plante M
    type
    Author
bibliography ids
  1. nci-bib-3d06115a65188403b66d3d7e
book metadata
content sha256
b63db0412c9debb17e04002dc937e57a1028ec384f57d6f45b499b06d405ee2e
document type
citation
dois
  1. 10.1016/S1470-2045(14)71135-0
electronic publication date
display
2014 Dec 4
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25481791
immutable id
pubmed:25481791@b63db0412c9debb17e04002dc937e57a1028ec384f57d6f45b499b06d405ee2e
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
87-97
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Feb;16(2):e55
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2015 Jan;16(1):e6
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  3. citation
    Lancet Oncol. 2015 Jan;16(1):10-2. doi: 10.1016/S1470-2045(14)71172-6.
    note
    Source null
    related pmid
    25481790
    relationship
    Comment in
outcomes validated
false
pmid
25481791
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
6b34d81aeb85a8cc99f5371af056277f9c39737940dbe8b71c95a63681a5f39a
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2015 Jan
precision
month
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25481791/
title
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

Preserved source evidence · Not medical advice